Recipharm Capabilities Update August 2026: Oral Solid Dose Formulation
How to turn development challenges into predictable outcomes
Recipharm’s development approach is designed to help you move faster from early formulation work to manufacturing readiness and transform complex formulation challenges into more predictable development outcomes.
In this session, you will learn how early material and process understanding can help reduce unnecessary experimentation, minimize reformulation and get it right first time. We will explore how material characterization, predictive modelling and Quality-by-Design principles can be applied to accelerate development and create a stronger foundation for successful scale-up and tech-transfer.
You will also see how these approaches are applied in practice through a case study demonstrating how data can be used to identify the most suitable manufacturing process, improve scalability and build robust formulations from the earliest stages of development.
You will leave with practical insights into how integrated development capabilities can help accelerate programs, reduce risk and support successful outcomes from development through to manufacturing.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.